Home > News > Technologies for Regenerative Medicine
February 27th, 2006
Technologies for Regenerative Medicine
Columbia University is a major contributor to the NanoMedicine Center for Mechanical Biology, a multi-disciplinary initiative aimed at developing new technologies for regenerative medicine and treating human diseases that involve mechanical malfunction, such as cancer.
The ultimate goal of the NanoMedicine Center for Mechanical Biology is to create an understanding of cellular mechanical biology which, once grasped, could lead to a pioneering operations manual for cell mechanical function. Since many diseases such as cancer, cardiovascular disease, osteoporosis, and immune disorders can originate from cell mechanical malfunction, this could provide important new technologies for treatments, i.e. a Cellular Repair Manual.
Imaging electric charge propagating along microbial nanowires October 20th, 2014
Superconducting circuits, simplified: New circuit design could unlock the power of experimental superconducting computer chips October 18th, 2014
Nanocoatings Market By Product Is Expected To Reach USD 8.17 Billion By 2020: Grand View Research, Inc. October 15th, 2014
Perpetuus Carbon Group Receives Independent Verification of its Production Capacity for Graphenes at 140 Tonnes per Annum: Perpetuus Becomes the First Manufacturer in the Sector to Allow Third Party Audit October 7th, 2014
Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014
Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014
Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014
TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014